Home Cart 0 Sign in  
X

[ CAS No. 105763-77-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 105763-77-7
Chemical Structure| 105763-77-7
Chemical Structure| 105763-77-7
Structure of 105763-77-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 105763-77-7 ]

Related Doc. of [ 105763-77-7 ]

Alternatived Products of [ 105763-77-7 ]

Product Details of [ 105763-77-7 ]

CAS No. :105763-77-7 MDL No. :MFCD09954880
Formula : C9H6Cl2N2O Boiling Point : -
Linear Structure Formula :- InChI Key :WEAMQTSRMCCGSJ-UHFFFAOYSA-N
M.W : 229.06 Pubchem ID :9991397
Synonyms :

Calculated chemistry of [ 105763-77-7 ]

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 10
Fraction Csp3 : 0.11
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 56.05
TPSA : 35.01 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.26 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.58
Log Po/w (XLOGP3) : 3.43
Log Po/w (WLOGP) : 2.95
Log Po/w (MLOGP) : 2.11
Log Po/w (SILICOS-IT) : 3.17
Consensus Log Po/w : 2.85

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.88
Solubility : 0.0299 mg/ml ; 0.000131 mol/l
Class : Soluble
Log S (Ali) : -3.85
Solubility : 0.0327 mg/ml ; 0.000143 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.7
Solubility : 0.00462 mg/ml ; 0.0000202 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.64

Safety of [ 105763-77-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 105763-77-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 105763-77-7 ]
  • Downstream synthetic route of [ 105763-77-7 ]

[ 105763-77-7 ] Synthesis Path-Upstream   1~6

  • 1
  • [ 32618-84-1 ]
  • [ 105763-77-7 ]
YieldReaction ConditionsOperation in experiment
98% at 120℃; for 2 h; Method F1: 2,4-Dichloro-6-methoxyquinazoline (x-a)
To a mixture of 6-methoxyquinazoline-2,4(1H, 3H)-dione (9.63 g, 50.2 mmol) in POCl3 (150 mL) was added N,N-dimethylaniline (0.5 mL).
The resulting mixture was stirred at 120° C. for 2 h.
After the reaction was completed, POCl3 was removed in vacuo, and the residue was added to ice-water slowly.
The pH was adjusted to ˜7 by slowly adding NaHCO3 (sat.) at 0° C., then a precipitate formed.
The solid was collected and dried in vacuo to give 11.2 g of 2,4-dichloro-6-methoxyquinazoline in a 98percent yield as a brown solid. LCMS m/z=229.1, 231.0 (M+1) (Method B) (retention time=1.87 min).
1H-NMR (400 MHz, DMSO-d6): δ 7.89 (d, J=9.2 Hz, 1H), 7.71 (dd, J=8.8, 2.4 Hz, 1H), 7.38 (d, J=1.6 Hz, 1H), 3.91 (s, 3H).
98% With trichlorophosphate In <i>N</i>,<i>N</i>-dimethyl-aniline at 120℃; for 12 h; To a mixture of 6-methoxyquinazoline-2,4 (1H, 3H) -dione (9.63 g, 50.2 mmol) in POCl 3 (150 mL)N, N-dimethylaniline (0.5 mL) was added.The resulting mixture was stirred at 120 ° C. for 2 hours.After the reaction was complete, the POCl 3 was removed in vacuo and the residue was slowly added to ice water.When the pH was adjusted to about 7 by the slow addition of saturated NaHCO 3 at 0 ° C., a precipitate formed.The solid was collected and dried under vacuum to afford 11.2 g of 2,4-dichloro-6-methoxyquinazoline as a brown solid (98percent yield).
82% for 5 h; Reflux A suspension of 6-methoxy-1H-quinazoline-2,4-dione (0.85 g, 4.42 mmol) and N,N-dimethylaniline (1.66 mL, 2.6 mmol) in phosphoryl chloride (6 mL, 65.5 mmol) was heated under reflux for 5 h.
The reaction mixture was cooled and poured into a beaker with ice, the precipitate was filtered off, washed with water and dried under vacuum to provide 0.82 g (82percent yield).
1H NMR (DMSO-d6) δ 8.01 (d, 1H), 7.03-7.80 (dd, 1H), 7.5 (d, 1H), 4.0 (s, 3H).
74%
Stage #1: at 20℃; for 0.5 h;
Stage #2: for 14 h; Reflux
General procedure: A mixture of quinazoline-2,4(1H,3H)-dione 4a (0.48 g, 2.96 mmol) in POCl3 (3.31 mL,35.52 mmol) was stirred at room temperature for 30 min. AfterN,N-diethylaniline (0.167 mL, 0.86 mmol) was added drop-wise,the reaction mixture was heated to reflux for 14 h. After cooling to rt, remained POCl3 was removed under reduced pressure. Thereaction residue was extracted three times with CH2Cl2 (30 mL),dried over MgSO4, concentrated under reduced pressure, and purifiedby column chromatography (EtOAc/n-Hex = 1:9) on silica gelto get the title product 5a in 87percent yield (513 mg).
69% for 16 h; Reflux A solution of 6-methoxyquinazoline- 2,4(lH,3H)-dione (5 g, 26.0 mmol) in trichloro phosphorus oxide (30 mL) was refluxed for 16 hours. After cooling down to ambient temperature, the resulting solution was concentrated under reduced pressure and the residue was purified by silica gel column chromatography, eluted with 1-2percent methanol in dichloromethane to afford 2,4-dichloro-6-methoxyquinazoline as a yellow solid: MS (ESI, m/z): 229 A [M + 1]+; 1H MR (300 MHz, CDC13) δ 7.90 (d, J= 9.3 Hz, 1H), 7.61 (dd, J= 2.7 Hz, 6.6 Hz, 1H), 7.41 (d, J= 2.7 Hz, 1H), 4.00 (s, 3H).
28% for 6 h; Reflux To a solution of 6-methoxyquinazoline-2,4(lH,3H)-dione (5.10 g, 26.6 mmol) in POCI3 (30 mL) was added N,N-diethylaniline (2.4 mL, 15.0 mmol). The mixture was refluxed for 6 hours. The excess POCI3 was removed under reduced pressure and the residue was dissolved in EtOAc (100 mL), the organic layer was washed with sat.NaHCC>3 (30 mL), dried over Na2S04, filtered and concentrated to give the crude product which was purified by silica gel column (PE / EtOAc=20 / 1) to give the product (1.70 g, yield 28percent).
3.6 g at 110℃; 2,4-dichloro-6-methoxyquinazoline
N,N-dimethylamine (6.3 mL, 50 mmol) was added into a mixed solution of 6-methoxyquinazolin-2,4(1H,3H)-dione (4.8 g, 25.0 mmol) prepared in Step 1 in phosphorus oxychloride (50 mL), and then they were stirred at 110° C. overnight.
After cooling to room temperature, the reaction mixture was added into ice water and then basified to pH 9 with sodium hydroxide.
The aqueous layer was extracted with ethyl acetate, and the organic layer was dried on anhydrous sodium sulfate and concentrated under reduced pressure.
The resulting residue was purified with silica gel column chromatography (n-hexane/ethyl acetate=5/1) to give the titled compound (3.6 g) as a yellow solid.

Reference: [1] Patent: US2015/307477, 2015, A1, . Location in patent: Paragraph 1497
[2] Patent: JP6121658, 2017, B2, . Location in patent: Paragraph 1096; 1099
[3] Patent: US2010/68197, 2010, A1, . Location in patent: Page/Page column 17
[4] Bioorganic and Medicinal Chemistry, 2003, vol. 11, # 11, p. 2439 - 2444
[5] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 24, p. 7717 - 7727
[6] Patent: WO2015/188368, 2015, A1, . Location in patent: Page/Page column 89
[7] Journal of Medicinal Chemistry, 1995, vol. 38, # 18, p. 3547 - 3557
[8] Patent: WO2012/83165, 2012, A1, . Location in patent: Page/Page column 96
[9] Journal of the Chemical Society, 1948, p. 1759,1765
[10] Journal of Medicinal Chemistry, 1995, vol. 38, # 14, p. 2763 - 2773
[11] Journal of Medicinal Chemistry, 2007, vol. 50, # 10, p. 2297 - 2300
[12] Journal of Medicinal Chemistry, 2014, vol. 57, # 12, p. 5141 - 5156
[13] Chemical and Pharmaceutical Bulletin, 2015, vol. 63, # 2, p. 75 - 80
[14] Patent: US2016/90374, 2016, A1, . Location in patent: Paragraph 0122
[15] Journal of Heterocyclic Chemistry, 2017, vol. 54, # 5, p. 2755 - 2766
  • 2
  • [ 32315-10-9 ]
  • [ 23842-82-2 ]
  • [ 105763-77-7 ]
Reference: [1] Heterocycles, 2012, vol. 85, # 6, p. 1417 - 1426
  • 3
  • [ 61948-86-5 ]
  • [ 105763-77-7 ]
Reference: [1] Patent: US5688803, 1997, A,
  • 4
  • [ 6705-03-9 ]
  • [ 105763-77-7 ]
Reference: [1] Journal of Medicinal Chemistry, 2007, vol. 50, # 10, p. 2297 - 2300
[2] Journal of Medicinal Chemistry, 1995, vol. 38, # 14, p. 2763 - 2773
[3] Journal of the Chemical Society, 1948, p. 1759,1765
[4] Patent: WO2012/83165, 2012, A1,
[5] Journal of Medicinal Chemistry, 2014, vol. 57, # 12, p. 5141 - 5156
[6] Chemical and Pharmaceutical Bulletin, 2015, vol. 63, # 2, p. 75 - 80
[7] Journal of Medicinal Chemistry, 2015, vol. 58, # 3, p. 1452 - 1465
[8] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 24, p. 7717 - 7727
[9] Patent: US2015/307477, 2015, A1,
[10] Patent: WO2015/188368, 2015, A1,
[11] Patent: US2016/90374, 2016, A1,
[12] Patent: JP6121658, 2017, B2,
[13] Patent: EP322133, 1989, A1,
  • 5
  • [ 1882-69-5 ]
  • [ 105763-77-7 ]
Reference: [1] Patent: US2015/307477, 2015, A1,
[2] Patent: JP6121658, 2017, B2,
  • 6
  • [ 57-13-6 ]
  • [ 6705-03-9 ]
  • [ 105763-77-7 ]
Reference: [1] Journal of Heterocyclic Chemistry, 2017, vol. 54, # 5, p. 2755 - 2766
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 105763-77-7 ]

Chlorides

Chemical Structure| 27631-29-4

[ 27631-29-4 ]

2,4-Dichloro-6,7-dimethoxyquinazoline

Similarity: 0.98

Chemical Structure| 60771-18-8

[ 60771-18-8 ]

7-(Benzyloxy)-2,4-dichloro-6-methoxyquinazoline

Similarity: 0.93

Chemical Structure| 61948-59-2

[ 61948-59-2 ]

2,4-Dichloro-5-methoxyquinazoline

Similarity: 0.91

Chemical Structure| 155960-92-2

[ 155960-92-2 ]

4-Chloro-6-ethoxyquinazoline

Similarity: 0.90

Chemical Structure| 55496-52-1

[ 55496-52-1 ]

4-Chloro-7-methoxyquinazoline

Similarity: 0.89

Ethers

Chemical Structure| 27631-29-4

[ 27631-29-4 ]

2,4-Dichloro-6,7-dimethoxyquinazoline

Similarity: 0.98

Chemical Structure| 60771-18-8

[ 60771-18-8 ]

7-(Benzyloxy)-2,4-dichloro-6-methoxyquinazoline

Similarity: 0.93

Chemical Structure| 61948-59-2

[ 61948-59-2 ]

2,4-Dichloro-5-methoxyquinazoline

Similarity: 0.91

Chemical Structure| 155960-92-2

[ 155960-92-2 ]

4-Chloro-6-ethoxyquinazoline

Similarity: 0.90

Chemical Structure| 55496-52-1

[ 55496-52-1 ]

4-Chloro-7-methoxyquinazoline

Similarity: 0.89

Related Parent Nucleus of
[ 105763-77-7 ]

Quinazolines

Chemical Structure| 27631-29-4

[ 27631-29-4 ]

2,4-Dichloro-6,7-dimethoxyquinazoline

Similarity: 0.98

Chemical Structure| 60771-18-8

[ 60771-18-8 ]

7-(Benzyloxy)-2,4-dichloro-6-methoxyquinazoline

Similarity: 0.93

Chemical Structure| 61948-59-2

[ 61948-59-2 ]

2,4-Dichloro-5-methoxyquinazoline

Similarity: 0.91

Chemical Structure| 155960-92-2

[ 155960-92-2 ]

4-Chloro-6-ethoxyquinazoline

Similarity: 0.90

Chemical Structure| 55496-52-1

[ 55496-52-1 ]

4-Chloro-7-methoxyquinazoline

Similarity: 0.89